"10.1371_journal.pone.0052484","plos one","2013-02-18T00:00:00Z","Soo Ghim Lim; Subbu S Venkatraman; John C Burnett; Horng H Chen","School of Materials Science and Engineering, Nanyang Technological University, Singapore, Singapore; Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, United States of America","Conceived and designed the experiments: SSV JCB HHC. Performed the experiments: SGL HHC. Analyzed the data: SGL SSV JCB HHC. Contributed reagents/materials/analysis tools: SSV JCB HHC. Wrote the paper: SGL SSV JCB HHC.","Cenderitide (CD-NP) has been licensed by the Mayo Clinic to Nile Therapeutics. Co-author Dr. Burnett is Chair of Nile Therapeutics Scientific Advisory Board. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","02","Soo Ghim Lim","SGL",4,TRUE,3,2,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
